Midterm outcomes after the rescue THV-in-THV procedure: Insights from the multicenter prospective OCEAN-TAVI registry.


Journal

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139

Informations de publication

Date de publication:
03 2021
Historique:
revised: 05 06 2020
received: 06 04 2020
accepted: 19 07 2020
pubmed: 14 8 2020
medline: 25 9 2021
entrez: 14 8 2020
Statut: ppublish

Résumé

To confirm whether the rescue transcatheter heart valve in the transcatheter heart valve (THV-in-THV) procedure is effective and feasible, we aimed to assess the midterm outcomes following rescue THV-in-THV procedures. The trends in the usage of the rescue THV-in-THV procedure at the time of transcatheter aortic valve implantation (TAVI) have also been explored. Midterm outcomes of the rescue THV-in-THV procedure have been poorly defined, though it is popular as an effective method to bail-out some complications in TAVI. We reviewed data from the Optimized transCathEter vAlvular iNtervention-Transcatheter Aortic Valve Implantation (OCEAN-TAVI) registry and compared the outcomes of TAVI with rescue THV-in-THV and TAVI without rescue THV-in-THV. We also examined the annual rates of rescue THV-in-THV procedures in all the TAVI procedures between 2013 and 2017. Among 2,588 patients who underwent TAVI, 26 patients have required rescue THV-in-THV for valve malposition (n = 23) or severe transvalvular regurgitation because of stuck THV leaflets (n = 3). Three cases needed an open conversion, and two died in the hospital. The rates of new permanent pacemaker implantation, acute kidney injury, and stroke were higher in the THV-in-THV group. A two-year cumulative survival and echocardiographic outcomes succeeding rescue THV-in-THV procedure were comparable to non-THV-in-THV cases. The rate of rescue THV-in-THV procedure lessened from 2.6% in 2013 to 0.6% in 2017. The rescue THV-in-THV procedure is an effective and feasible option for THV malpositioning and stuck valve. It has given a comparable survival and a stable valve function over midterm observation periods.

Sections du résumé

OBJECTIVES
To confirm whether the rescue transcatheter heart valve in the transcatheter heart valve (THV-in-THV) procedure is effective and feasible, we aimed to assess the midterm outcomes following rescue THV-in-THV procedures. The trends in the usage of the rescue THV-in-THV procedure at the time of transcatheter aortic valve implantation (TAVI) have also been explored.
BACKGROUND
Midterm outcomes of the rescue THV-in-THV procedure have been poorly defined, though it is popular as an effective method to bail-out some complications in TAVI.
METHODS
We reviewed data from the Optimized transCathEter vAlvular iNtervention-Transcatheter Aortic Valve Implantation (OCEAN-TAVI) registry and compared the outcomes of TAVI with rescue THV-in-THV and TAVI without rescue THV-in-THV. We also examined the annual rates of rescue THV-in-THV procedures in all the TAVI procedures between 2013 and 2017.
RESULTS
Among 2,588 patients who underwent TAVI, 26 patients have required rescue THV-in-THV for valve malposition (n = 23) or severe transvalvular regurgitation because of stuck THV leaflets (n = 3). Three cases needed an open conversion, and two died in the hospital. The rates of new permanent pacemaker implantation, acute kidney injury, and stroke were higher in the THV-in-THV group. A two-year cumulative survival and echocardiographic outcomes succeeding rescue THV-in-THV procedure were comparable to non-THV-in-THV cases. The rate of rescue THV-in-THV procedure lessened from 2.6% in 2013 to 0.6% in 2017.
CONCLUSIONS
The rescue THV-in-THV procedure is an effective and feasible option for THV malpositioning and stuck valve. It has given a comparable survival and a stable valve function over midterm observation periods.

Identifiants

pubmed: 32790158
doi: 10.1002/ccd.29175
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

701-711

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Nishimura RA, Otto CM, Bonow RO, et al. AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association task Force on Clinical Practice Guidelines. Circulation. 2017;135:e1159-e1195.
Baumgartner H, Falk V, Bax JJ, et al. ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739-2791.
Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380:1695-1705.
Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380:1706-1715.
Ruiz CE, Laborde JC, Condado JF, Chiam PTL, Condado JA. First percutaneous transcatheter aortic valve-in-valve implant with three year follow-up. Catheter Cardiovasc Interv. 2008;72:143-148.
Napodano M, Gasparetto V, Tarantini G, et al. Performance of valve-in-valve for severe para-prosthetic leaks due to inadequate transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2011;78:996-1003.
Ussia GP, Barbanti M, Ramondo A, et al. The valve-in-valve technique for treatment of aortic bioprosthesis malposition: an analysis of incidence and 1-year clinical outcomes from the Italian CoreValve registry. J Am Coll Cardiol. 2011;57:1062-1068.
Makkar RR, Jilaihawi H, Chakravarty T, et al. Determinants and outcomes of acute transcatheter valve-in-valve therapy or embolization: a study of multiple valve implants in the U.S. PARTNER trial (placement of AoRTic TraNscathetER valve trial Edwards SAPIEN transcatheter heart valve). J Am Coll Cardiol. 2013;62:418-430.
Piazza N, Schultz C, de Jaegere PPT, Serruys PW. Implantation of two self-expanding aortic bioprosthetic valves during the same procedure-insights into valve-in-valve implantation (“Russian doll concept”). Catheter Cardiovasc Interv. 2009;73:530-539.
Toggweiler S, Wood DA, Rodés-Cabau J, et al. Transcatheter valve-in-valve implantation for failed balloon-expandable transcatheter aortic valves. JACC Cardiovasc Interv. 2012;5:571-577.
Kappetein AP, Head SJ, Genereux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research Consortium-2 consensus document. Eur Heart J. 2012;33:2403-2418.
O'Brien SM, Shahian DM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2-isolated valve surgery. Ann Thorac Surg. 2009;88:S23-S42.
Dolgin M, New York Heart Association, Criteria Committee. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9th ed. New York, NY: Little, Brown and Co; 1994.
Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. Can Med Assoc J. 2005;173:489-495.
Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: a call to action. J Am Med Dir Assoc. 2013;14:392-397.
Shimura T, Yamamoto M, Kano S, et al. Impact of the clinical frailty scale on outcomes after transcatheter aortic valve replacement. Circulation. 2017;135:2013-2024.
Yu Y, Vallely M, Ng MK. Valve-in-valve implantation for aortic annular rupture complicating transcatheter aortic valve replacement (TAVR). J Invasive Cardiol. 2013;25:409-410.
Rezq A, Basavarajaiah S, Latib A, et al. Incidence, management, and outcomes of cardiac tamponade during transcatheter aortic valve implantation. A single-center study. JACC Cardiovasc Interv. 2012;5:1264-1272.
Giannini F, Montorfano M, Romano V, et al. Valve embolization with a second-generation fully-retrievable and repositionable transcatheter aortic valve. Int J Cardiol. 2016;223:867-869.
Maeno Y, Yoon SH, Abramowitz Y, et al. Effect of ascending aortic dimension on acute procedural success following self-expanding transcatheter aortic valve replacement. A multicenter retrospective analysis. Int J Cardiol. 2017;244:100-105.
Kaneko H, Hoelschermann F, Tambor G, Yoon SH, Neuss M, Butter C. Predictors of paravalvular regurgitation after Transcatheter aortic valve implantation for aortic stenosis using new-generation balloon-expandable SAPIEN 3. Am J Cardiol. 2017;119:618-622.
Yamamoto M, Hayashida K, Mouillet G, et al. Renal function-based contrast dosing predicts acute kidney injury following transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2013;6:479-486.
MacDonald I, Pasupati S. Transcatheter aortic valve implantation: know the differences between the currently available technologies. Eur Heart J. 2010;31:1663-1665.
Young Lee M, Chilakamarri Yeshwant S, Chava S, Lawrence Lustgarten D. Mechanisms of heart block after transcatheter aortic valve replacement - cardiac anatomy, clinical predictors and mechanical factors that contribute to permanent pacemaker implantation. Arrhythmia Electrophysiol Rev. 2015;4:81-85.
Webb JG, Murdoch DJ, Alu MC, et al. 3-year outcomes after valve-in-valve transcatheter aortic valve replacement for degenerated bioprostheses: the PARTNER 2 registry. J Am Coll Cardiol. 2019;73:2647-2655.
Carroll JD, Vemulapalli S, Dai D, et al. Procedural experience for transcatheter aortic valve replacement and relation to outcomes: the STS/ACC TVT Registry. J Am Coll Cardiol. 2017;70:29-41.

Auteurs

Makoto Hibino (M)

Department of Cardiovascular Surgery, Tokyo Bay Urayasu-Ichikawa Medical Center, Chiba, Japan.

Minoru Tabata (M)

Department of Cardiovascular Surgery, Tokyo Bay Urayasu-Ichikawa Medical Center, Chiba, Japan.

Joji Ito (J)

Department of Cardiovascular Surgery, Tokyo Bay Urayasu-Ichikawa Medical Center, Chiba, Japan.

Kentaro Shibayama (K)

Department of Cardiology, Tokyo Bay Urayasu-Ichikawa Medical Center, Chiba, Japan.

Kotaro Obunai (K)

Department of Cardiology, Tokyo Bay Urayasu-Ichikawa Medical Center, Chiba, Japan.

Hiroyuki Watanabe (H)

Department of Cardiology, Tokyo Bay Urayasu-Ichikawa Medical Center, Chiba, Japan.

Norio Tada (N)

Cardiovascular Center, Sendai Kosei Hospital, Sendai, Japan.

Toru Naganuma (T)

Interventional Cardiology Unit, New Tokyo Hospital, Chiba, Japan.

Motoharu Araki (M)

Department of Cardiovascular Medicine, Saiseikai Yokohama City Eastern Hospital, Kanagawa, Japan.

Futoshi Yamanaka (F)

Department of Cardiovascular Medicine, Shonan Kamakura General Hospital, Kanagawa, Japan.

Hiroshi Ueno (H)

Department of Cardiovascular Medicine, Toyama University School of Medicine, Toyama, Japan.

Kazuki Mizutani (K)

Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.

Akihiro Higashimori (A)

Department of Cardiology, Kishiwada Tokushukai Hospital, Osaka, Japan.

Kensuke Takagi (K)

Department of Cardiology, Ogaki Municipal Hospital, Gifu, Japan.

Yusuke Watanabe (Y)

Division of Cardiology, Department of Internal Medicine, Teikyo University, Tokyo, Japan.

Shinichi Shirai (S)

Department of Cardiology, Kokura Memorial Hospital, Kokura, Japan.

Masanori Yamamoto (M)

Division of Cardiovascular Medicine, Toyohashi Heart Center, Toyohashi, Japan.
Department of Cardiology, Nagoya Heart Center, Nagoya, Japan.

Kentaro Hayashida (K)

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH